Our results suggest that further investigation into additional factors including changes in aromatase activity that can synergize with hyperandrogenism to drive metabolic dysregulation in females could be informative in understanding PCOS pathology and potential therapeutic interventions. Here, CYP19A1 is linked to polycystic ovary syndrome.